Status:
UNKNOWN
The Role of Ketamine in Preventing Cognitive Dysfunctions in Postoperative Period of Cardiac Surgery
Lead Sponsor:
Flavia orange
Collaborating Sponsors:
Rebeca Gonelli Albanez da Cunha Andrade
Conditions:
Delirium
Inflammation
Eligibility:
All Genders
50+ years
Phase:
PHASE4
Brief Summary
The purpose of this study is to analyze the Ketamine with its anti-inflammatory profile would be able to prevent cognitive disorders in the postoperative period of cardiac surgery, since these disorde...
Eligibility Criteria
Inclusion
- Patients aged over 50 years.
- Be submitted to cardiac surgery by sternotomy and with the use of cardiopulmonary bypass (CPB).
- American Society of Anesthesiologists classification 1, 2,3 and 4.
Exclusion
- Patients undergoing reoperation.
- Patients undergoing heart transplantation.
- Patients using vasopressor agents and / or ionotropic continuous preoperatively.
- Patients with prior endotracheal intubation and consequently Ventilatory Assistance Mechanics.
- Patients with documented psychiatric disorders.
- Patients with previous cognitive disorders.
- Patients with a history of alcohol or drug abuse.
- Patients with a history of cerebrovascular accident (CVA) with less than 3 months.
Key Trial Info
Start Date :
April 1 2016
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT02782429
Start Date
April 1 2016
Last Update
May 25 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Instituto de Medicina Integral Prof Fernando Figueira
Recife, Pernambuco, Brazil, 50070-550